
The submission of 24-month efficacy data from DERBY and OAKS is classified as a Major Amendment to the New Drug Application, which delays the PDUFA target action date until February 2023.

The submission of 24-month efficacy data from DERBY and OAKS is classified as a Major Amendment to the New Drug Application, which delays the PDUFA target action date until February 2023.

The main outcome measures were the baseline cataract severity and self-reported cataract surgery at a 15-year visit.

Preservative-free eye drops offer benefits for ocular health.

Enhanced treatments, tools, and resources make a difference.

Advanced planning is the key for the most successful practice transitions as well as realizing the highest return on investment on the sale.

The CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.

Optometrists may be the first, or only, touchpoint that patients have with the healthcare system.

When interpreting study findings, take into consideration the similarity and the differences between the subjects recruited for the study versus the patient population each practitioner serves.

Presbyopia-correcting drops for patients with low, up-close visual function.

Obesity can affect retinal structures differently.

This research collaboration between Chinese and Australian researchers set out to investigate the connection in the UK Biobank Study cohort.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

It was reported that the more individuals smoke, the faster the retinal nerve fiber layer (RNFL) becomes thinner.

Awareness of visual impairment in clinical practice is suboptimal, and adherence to ophthalmologic evaluation needs to be improved. The prospective cohort study in the Netherlands included 170 children aged 0 to 18 years with a newly diagnosed brain tumor.

Katherine M. Mastrota, OD, FAAO, advises on how to diagnosis this condition and not fall prey to a “knee-jerk” dry eye diagnosis.

World Sight Day is upon us and RestoringVision has issued a lofty but doable goal: help solve the global vision crisis.

In honor of World Sight Day, optometrists and ophthalmologists reflect on what today means to them.

DigitalOptometrics President discusses the pioneering abilities of telemedicine and how the company is paving a new way for doctors to see patients of varying needs.

Treatment suspension has negative impact on visual function.

A robust online presence is crucial if you’re looking to acquire new patients, grow your practice, and increase revenue.

Several risk factors beyond intraocular pressure contribute to open-angle glaucoma.

This case illustrates stability of an extrafoveal lesion without vision loss.

The event is part of the organization's pipeline for Black students into optometry.

The web-based, self-guided software application is accessed through touchscreen mobile devices.

Eyecare practitioners' top misconceptions just may surprise you.

A recent report shows that 61 drugs were associated with the development of acute angle-closure (AAC) glaucoma.

Water gradient tech, high-tech materials, and new therapies offer more options.

Potential for treatment strategy to prevent blindness from glaucoma.

When considering the best modality these lenses' stability are superior.

Johnson & Johnson Vision receives FDA-approval of lens parameter expansion for their ACUVUE Abiliti Overnight Therapeutic Lenses for Myopia Management.